In silico study of the mechanisms of hypoxia and contractile dysfunction during ischemia and reperfusion of hiPSC...

Area of Science:

• Cardiology
• Computational Biology
• Stem Cell Research

Background:

• Ischemia-reperfusion (IR) injury is a critical concern in cardiovascular research.
• Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) offer a valuable in vitro model for studying cardiac pathologies.
• Understanding the intricate mechanisms of IR injury is essential for developing effective therapeutic strategies.

Purpose of the Study:

• To develop and validate a whole-cell computational model of hiPSC-CMs that integrates electromechanics, metabolite-sensitive sarcoplasmic reticulum Ca2+-ATPase (SERCA), and oxygen dynamics.
• To investigate the mechanisms underlying IR injury in hiPSC-CMs.
• To simulate the effects and elucidate the action mechanism of levosimendan in the context of IR and hypoxia.

Main Methods:

• Development of a comprehensive whole-cell computational model of hiPSC-CMs.
• Incorporation of electromechanics, a metabolite-sensitive SERCA, and oxygen dynamics into the model.
• Simulation of levosimendan's effects and validation against hiPSC-CM and in vitro animal data.

Main Results:

• The computational model successfully replicated key aspects of IR injury in hiPSC-CMs.
• Levosimendan was shown to counteract relaxation dysfunction via a Ca2+-sensitizing mechanism, not by inhibiting SERCA phosphorylation.
• The model identified a comparable role for SERCA in IR and sepsis-induced heart failure relaxation dysfunction.

Conclusions:

• The developed computational model provides a robust platform for studying IR mechanisms in hiPSC-CMs.
• Levosimendan's anti-arrhythmic effects are attributed to a specific Ca2+-sensitizing pathway.
• The model holds significant promise for drug development and evaluating therapeutic strategies for IR injury.